Leukocyte filtration in cardiac surgery: A review

Perfusion

Volumn 16, Issue 5, 2001, Pages 361-370

  Matheis, G ^a   Scholz, M ^a   Simon, A ^a   Dzemali, Omer ^a   Moritz, A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD FILTRATION; CARDIOPULMONARY BYPASS; CELL FUNCTION; CONTROLLED STUDY; EFFECTOR CELL; HEART LUNG TRANSPLANTATION; HEART SURGERY; HUMAN; LABORATORY TEST; LEUKAPHERESIS; LEUKOCYTE ACTIVATION; LEUKOPENIA; PATHOGENICITY; PRIORITY JOURNAL; REVIEW; TECHNOLOGY; TISSUE INJURY; TREATMENT OUTCOME;

ADULT; ANIMALS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CATHETERIZATION, PERIPHERAL; CATHETERS, INDWELLING; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM, VASCULAR; FILTRATION; HEART ARREST, INDUCED; HEART DEFECTS, CONGENITAL; HEART-LUNG TRANSPLANTATION; HUMANS; INFANT; INTERLEUKIN-8; INTRAOPERATIVE COMPLICATIONS; LEUKOCYTES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; LYMPHOKINES; NEUTROPHILS; OXIDATIVE STRESS; RETROSPECTIVE STUDIES; SUCTION; SWINE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0034837404     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/026765910101600506     Document Type: Article

References (76)

1. Molecular mechanisms that control endothelial cell contacts
2. Cardiopulmonary bypass-induced inflammation: Is it important?
3. Amplification of the inflammatory response: Adhesion molecules associated with platelet/white cell responses
4. Initiation of white cell activation during cardiopulmonary bypass: Cytokines and receptors
5. Complement and the damaging effects of cardiopulmonary bypass
6. Inflammatory response to cardiopulmonary bypass
7. Leukocyte depletion results in improved lung function and reduced inflammatory response after cardiac surgery
8. Xanthine oxidase mediates elastase-induced injury to isolated lungs and endothelium
9. Reperfusion-induced leukocyte infiltration: Role of elastase
10. Neutrophil elastase and oxygen radicals: Synergism in lung injury after hindlimb ischemia
11. 4-induced lung injury in rabbit
12. Role of L-argininenitric oxide pathway in myocardial reoxygenation injury
13. Cardiopulmonary dysfunction produced by reoxygenation of immature hypoxemic animals supported by cardiopulmonary bypass. Prevention by intravenous metabolic pretreatment
14. The systemic inflammatory response to cardiopulmonary bypass: Pathophysiological, therapeutic, and pharmacological considerations
15. Inflammatory response to cardiopulmonary bypass: Mechanisms involved and possible therapeutic strategies
16. Corticosteroids during operations using cardiopulmonary bypass
17. Steroids in cardiopulmonary bypass
18. Controlling the complement system in inflammation
19. Synthetic protein treated versus heparin coated cardiopulmonary bypass surfaces: Similar clinical results and minor biochemical differences
20. Normoxic cardiopulmonary bypass reduces oxidative myocardial damage and nitric oxide during cardiac operations in the adult
21. Myocardial protection in hypoxic immature hearts
22. A simple method of removing leukocytes from blood
23. On some new methods, devices and apparatus for the routine and the research laboratory
24. Removal of leukocytes from whole blood and erythrocyte suspensions by filtration through cotton wool. I. Filtration technique
25. The removal of leukocytes and platelets from whole blood
26. Leukocyte depletion of red cell units at the bedside by transfusion through a new filter
27. Biocompatibility of leukocyte removal filters during bedside leukocyte filtration of red cell concentrates
28. Leukocyte depletion reduces postoperative inflammatory response in patients following open-heart surgery
29. Leukocyte-depleted reperfusion of transplanted human hearts: A randomized, double blind clinical trial
30. Reduced platelet activation and improved hemostasis after controlled cardiotomy suction during clinical membrane oxygenator perfusions
31. Bleeding complications associated with cardiopulmonary bypass
32. Mechanisms of white cell reduction in red cell concentrates by filtration: The effect of the cellular composition of the red cell concentrates
33. Electron microscopic examination of white cell reduction by four white cell-reduction filters
34. Laboratory evaluation of the Pall LG6 leukocyte depleting arterial line filter
35. Depletion of activated neutrophils by a filter during cardiac valve surgery
36. Clinical evaluation of the new Pall leucocyte-depleting blood cardioplegia filter (BC1)
37. Prevention of reperfusion injury in the neonatal heart with leukocyte depleted blood
38. Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass
39. Temporary leukocyte depletion reduces ventricular dysfunction during prolonged postischemic reperfusion
40. Pall leukocyte depleting filter during cardiopulmonary bypass
41. Leukocyte depletion reduces postoperative oxygen requirements
42. Depletion of neutrophils by filter during aortocoronary bypass surgery transiently improves postoperative cardiorespiratory status
43. The influence of leukocyte filtration during cardiopulmonary bypass on postoperative lung function: A clinical study
44. Clinical performance of a high efficacy rapid flow leukocyte removal filter for leukocyte depletion of heparinized cardiopulmonary bypass perfusate
45. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate
46. The protective effect of a leucocyte removal filter on the lung in open-heart surgery for ventricular septal defect
47. Leukocyte depletion during cardiac operation: A new approach through the venous bypass circuit
48. Filtration of activated granulocytes during cardiopulmonary bypass surgery: A morphologic and immunologic study to characterize the trapped leukocytes
49. Twenty-four hour lung preservation by hypothermia and leukocyte depletion
50. Leukocyte depletion results in excellent heart-lung function after 12h of storage
51. Successful twenty-four hour lung preservation with donor core cooling and leukocyte depletion in an orthotopic double lung transplantation model
52. Use of leukocyte depletion to decrease injury after lung preservation and rewarming ischemia: An experimental model
53. Complete functional recovery after 24-hour heart preservation with University of Wisconsin solution and modified reperfusion
54. Effects of terminal cardioplegia with leukocyte-depleted blood on heart grafts preserved for 24 h
55. Reduced neutrophil infiltration protects against lung reperfusion injury after transplantation
56. Modifying risk for extracorporeal circulation: Trial of four antiinflammatory strategies
57. Leucocyte filtration during cardiopulmonary reperfusion in coronary artery bypass surgery
58. Efficiency and safety of leukocyte filtration during cardiopulmonary bypass for cardiac surgery
59. Leukocyte-depleted reperfusion after long cardioplegic arrest attenuates ischemia-reperfusion injury of the coronary endothelium and myocardium in rabbit hearts
60. Evaluation of leukocyte-reducing arterial line filter (LG6) for postoperative lung function, using cardiopulmonary bypass
61. Clinical evaluation of the LeukoGuard (LG6) arterial line filter for routine open heart surgery
62. Effects of a leucocyte depleting arterial line filter on perioperative proteolytic enzyme and oxygen free radical release in patients undergoing aortocoronary bypass surgery
63. Our experience with using the Pall LG6 leukocyte depleting filter during cardiopulmonary bypass
64. Efficacy of leukocyte filters in the bypass circuit for infants undergoing cardiac operations
65. Cardiopulmonary bypass circuit treated with surface-modifying additives: A clinical evaluation of blood compatibility
66. Pulsatile reperfusion: The effects on coronary blood flow and myocardial ischemic injury
67. Oxygenated cardioplegia: Blood is a many splendored thing
68. Clinical evaluation of a leucocyte-depleting blood cardioplegia filter (BC1B) for elective open-heart surgery
69. Studies of controlled reperfusion after ischemia. XXII. Reperfusate composition: Effects of leukocyte depletion of blood and blood cardioplegic reperfusates after acute coronary occlusion
70. Leukocyte depletion of blood cardioplegia attenuates reperfusion injury
71. Platelet-activating factor plays an important role in reperfusion injury in myocardium. Efficacy of platelet-activating factor receptor antagonist (CV-3988) as compared with leukocyte-depleted reperfusion
72. The effects of using a leukocyte removal filter during cold blood cardioplegia
73. Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation
74. The effect of leukocyte-depleted blood cardioplegia in patients with severe left ventricular dysfunction: A randomized, double-blind study
75. Leukocyte filtration in the early reperfusion phase on cardiopulmonary bypass reduces myocardial injury
76. Timing of leukocyte filtration during cardiopulmonary bypass